Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence

WC Dai, TT Cheung - Expert Review of Anticancer Therapy, 2016 - Taylor & Francis
Introduction: The long-term survival after hepatectomy for HCC remains unsatisfactory
because of the high incidence of recurrence. The cumulative 5-year recurrence rate ranged …
被引用次数：24 相关文章

[引用][C] Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence

WC Dai, TT Cheung - Expert Review of Anticancer Therapy: an essential …, 2016 - hub.hku.hk
HKU Scholars Hub: Strategic overview on the best treatment option for intrahepaitc
hepatocellular carcinoma recurrence Skip navigation HKU Login Guest Login Home …

Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence.

WC Dai, TT Cheung - Expert Review of Anticancer Therapy, 2016 - europepmc.org
The long-term survival after hepatectomy for HCC remains unsatisfactory because of the
high incidence of recurrence. The cumulative 5-year recurrence rate ranged from 60-100 …

Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence

WC Dai, TT Cheung - Expert review of anticancer therapy, 2016 - pubmed.ncbi.nlm.nih.gov
Introduction The long-term survival after hepatectomy for HCC remains unsatisfactory
because of the high incidence of recurrence. The cumulative 5-year recurrence rate ranged …